HIGHLIGHTS
- who: China CDC Weekly and collaborators from the Chinese Center forPeking University Research, China have published the research work: Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A, in the Journal: (JOURNAL) of November/16,/2022
- what: In this study a cross-sectional survey was conducted among 502 diabetic inpatients from two hospitals in Hospital Peking University Shenzhen) and Changzhi Heping Hospital ). The participants anonymously filled out an online questionnaire survey between April and June 2022 after informed consent of the study objectives was collected.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.